First time compassionate use of laboratory engineered autologous Zurich skin in a massively burned child

Managing major pediatric burns remains a challenge for the entire multidisciplinary team. Limited donor sites make complete early wound closure impossible and the need for temporary cover options and ideally autologous cultured skin increases. We report the case of a 5 year-old child with a 95% tota...

Full description

Bibliographic Details
Main Authors: Naiem Moiemen, Clemens Schiestl, Fabienne Hartmann-Fritsch, Kathrin Neuhaus, Ernst Reichmann, Arina Löw, Chantal Stenger, Sophie Böttcher-Haberzeth, Martin Meuli
Format: Article
Language:English
Published: Elsevier 2021-07-01
Series:Burns Open
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2468912221000146
id doaj-1e0fd6f751104efd8db4518d77fda82d
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Naiem Moiemen
Clemens Schiestl
Fabienne Hartmann-Fritsch
Kathrin Neuhaus
Ernst Reichmann
Arina Löw
Chantal Stenger
Sophie Böttcher-Haberzeth
Martin Meuli
spellingShingle Naiem Moiemen
Clemens Schiestl
Fabienne Hartmann-Fritsch
Kathrin Neuhaus
Ernst Reichmann
Arina Löw
Chantal Stenger
Sophie Böttcher-Haberzeth
Martin Meuli
First time compassionate use of laboratory engineered autologous Zurich skin in a massively burned child
Burns Open
Tissue engineering
Skin substitute
Skin analogue
Burns
Compassionate use
Child
author_facet Naiem Moiemen
Clemens Schiestl
Fabienne Hartmann-Fritsch
Kathrin Neuhaus
Ernst Reichmann
Arina Löw
Chantal Stenger
Sophie Böttcher-Haberzeth
Martin Meuli
author_sort Naiem Moiemen
title First time compassionate use of laboratory engineered autologous Zurich skin in a massively burned child
title_short First time compassionate use of laboratory engineered autologous Zurich skin in a massively burned child
title_full First time compassionate use of laboratory engineered autologous Zurich skin in a massively burned child
title_fullStr First time compassionate use of laboratory engineered autologous Zurich skin in a massively burned child
title_full_unstemmed First time compassionate use of laboratory engineered autologous Zurich skin in a massively burned child
title_sort first time compassionate use of laboratory engineered autologous zurich skin in a massively burned child
publisher Elsevier
series Burns Open
issn 2468-9122
publishDate 2021-07-01
description Managing major pediatric burns remains a challenge for the entire multidisciplinary team. Limited donor sites make complete early wound closure impossible and the need for temporary cover options and ideally autologous cultured skin increases. We report the case of a 5 year-old child with a 95% total body surface area (TBSA) deep flame burn and the large scale application of a laboratory grown, autologous dermo-epidermal skin analogue, termed Zurich Skin, justified and permitted as compassionate use. In total, 1626 cm2 of Zurich Skin were transplanted onto the patient, relating to approximately 20% of its TBSA. Zurich Skin was easy to handle and apply, showed excellent engraftment rates of 80–90% over dermal substitutes as well as over allodermal remnants, and after a maturation process lead to a soft and solid, close to natural skin coverage. Unfortunately, the child died after a prolonged and intense struggle due to multiple organ failure. This case delivers the clinical proof of principle that Zurich Skin has the potential to help substantially in acute cases with massive skin loss.
topic Tissue engineering
Skin substitute
Skin analogue
Burns
Compassionate use
Child
url http://www.sciencedirect.com/science/article/pii/S2468912221000146
work_keys_str_mv AT naiemmoiemen firsttimecompassionateuseoflaboratoryengineeredautologouszurichskininamassivelyburnedchild
AT clemensschiestl firsttimecompassionateuseoflaboratoryengineeredautologouszurichskininamassivelyburnedchild
AT fabiennehartmannfritsch firsttimecompassionateuseoflaboratoryengineeredautologouszurichskininamassivelyburnedchild
AT kathrinneuhaus firsttimecompassionateuseoflaboratoryengineeredautologouszurichskininamassivelyburnedchild
AT ernstreichmann firsttimecompassionateuseoflaboratoryengineeredautologouszurichskininamassivelyburnedchild
AT arinalow firsttimecompassionateuseoflaboratoryengineeredautologouszurichskininamassivelyburnedchild
AT chantalstenger firsttimecompassionateuseoflaboratoryengineeredautologouszurichskininamassivelyburnedchild
AT sophiebottcherhaberzeth firsttimecompassionateuseoflaboratoryengineeredautologouszurichskininamassivelyburnedchild
AT martinmeuli firsttimecompassionateuseoflaboratoryengineeredautologouszurichskininamassivelyburnedchild
_version_ 1721309422213398528
spelling doaj-1e0fd6f751104efd8db4518d77fda82d2021-07-11T04:28:49ZengElsevierBurns Open2468-91222021-07-0153113117First time compassionate use of laboratory engineered autologous Zurich skin in a massively burned childNaiem Moiemen0Clemens Schiestl1Fabienne Hartmann-Fritsch2Kathrin Neuhaus3Ernst Reichmann4Arina Löw5Chantal Stenger6Sophie Böttcher-Haberzeth7Martin Meuli8Birmingham Children Hospital Foundation Trust, University Hospitals Birmingham Foundation Trust, Centre for Conflict Wound Research, Steelhouse Lane, Birmingham B4 6NH, United KingdomDepartment of Pediatric Surgery, University Children's Hospital Zurich, University of Zurich, Steinwiesstrasse 75, 8032 Zurich, Switzerland; Pediatric Burn Center, Children’s Skin Center, Department of Pediatric Surgery, University Children’s Hospital Zurich, University of Zurich, Steinwiesstrasse 75, 8032 Zurich, Switzerland; Children's Research Center (CRC), University Children’s Hospital Zurich, University of Zurich, Steinwiesstrasse 75, 8032 Zurich, SwitzerlandWyss Zurich Regenerative Medicine Technologies Platform, ETH Zurich and University of Zurich, Weinbergstrasse 35, 8092 Zurich, SwitzerlandDepartment of Pediatric Surgery, University Children's Hospital Zurich, University of Zurich, Steinwiesstrasse 75, 8032 Zurich, Switzerland; Pediatric Burn Center, Children’s Skin Center, Department of Pediatric Surgery, University Children’s Hospital Zurich, University of Zurich, Steinwiesstrasse 75, 8032 Zurich, Switzerland; Children's Research Center (CRC), University Children’s Hospital Zurich, University of Zurich, Steinwiesstrasse 75, 8032 Zurich, SwitzerlandDepartment of Pediatric Surgery, University Children's Hospital Zurich, University of Zurich, Steinwiesstrasse 75, 8032 Zurich, Switzerland; Children's Research Center (CRC), University Children’s Hospital Zurich, University of Zurich, Steinwiesstrasse 75, 8032 Zurich, Switzerland; Tissue Biology Research Unit, Department of Pediatric Surgery, University Children's Hospital Zurich, Wagistrasse 12, 8952 Schlieren, SwitzerlandWyss Zurich Regenerative Medicine Technologies Platform, ETH Zurich and University of Zurich, Weinbergstrasse 35, 8092 Zurich, SwitzerlandWyss Zurich Regenerative Medicine Technologies Platform, ETH Zurich and University of Zurich, Weinbergstrasse 35, 8092 Zurich, SwitzerlandDepartment of Pediatric Surgery, University Children's Hospital Zurich, University of Zurich, Steinwiesstrasse 75, 8032 Zurich, Switzerland; Pediatric Burn Center, Children’s Skin Center, Department of Pediatric Surgery, University Children’s Hospital Zurich, University of Zurich, Steinwiesstrasse 75, 8032 Zurich, Switzerland; Children's Research Center (CRC), University Children’s Hospital Zurich, University of Zurich, Steinwiesstrasse 75, 8032 Zurich, Switzerland; Corresponding author at: Department of Pediatric Surgery, University Children's Hospital Zurich, University of Zurich, Steinwiesstrasse 75, 8032 Zurich, Switzerland.Department of Pediatric Surgery, University Children's Hospital Zurich, University of Zurich, Steinwiesstrasse 75, 8032 Zurich, Switzerland; Pediatric Burn Center, Children’s Skin Center, Department of Pediatric Surgery, University Children’s Hospital Zurich, University of Zurich, Steinwiesstrasse 75, 8032 Zurich, Switzerland; Children's Research Center (CRC), University Children’s Hospital Zurich, University of Zurich, Steinwiesstrasse 75, 8032 Zurich, SwitzerlandManaging major pediatric burns remains a challenge for the entire multidisciplinary team. Limited donor sites make complete early wound closure impossible and the need for temporary cover options and ideally autologous cultured skin increases. We report the case of a 5 year-old child with a 95% total body surface area (TBSA) deep flame burn and the large scale application of a laboratory grown, autologous dermo-epidermal skin analogue, termed Zurich Skin, justified and permitted as compassionate use. In total, 1626 cm2 of Zurich Skin were transplanted onto the patient, relating to approximately 20% of its TBSA. Zurich Skin was easy to handle and apply, showed excellent engraftment rates of 80–90% over dermal substitutes as well as over allodermal remnants, and after a maturation process lead to a soft and solid, close to natural skin coverage. Unfortunately, the child died after a prolonged and intense struggle due to multiple organ failure. This case delivers the clinical proof of principle that Zurich Skin has the potential to help substantially in acute cases with massive skin loss.http://www.sciencedirect.com/science/article/pii/S2468912221000146Tissue engineeringSkin substituteSkin analogueBurnsCompassionate useChild